{"nct_id":"NCT01962974","title":"A Golimumab Phase 3b, Multicenter, Assessment of Intravenous Efficacy in Rheumatoid Arthritis Subjects Who Have Diminished Disease Control Despite Treatment With Infliximab (REMICADE®)","status":"TERMINATED","status_verified_date":"2017-03","start_date":"2013-10","start_date_type":null,"primary_completion_date":"2014-12","primary_completion_date_type":"ACTUAL","completion_date":"2014-12","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["JNJ"]}